SCHEMBL6546027

SCHEMBL6546027

CCc1cccc(C)c1NC(=O)CCl

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.61
ALDH1A1 P00352 4/20 0.57
HTT P42858 3/20 0.57
NLRP3 Q96P20 1/20 0.55
HSD17B10 Q99714 2/20 0.54
SMN1; SMN2 Q16637 4/20 0.53
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
NPSR1 Q6W5P4 1/20 0.52
LMNA P02545 3/20 0.51
MAPT P10636 3/20 0.51
SCN3A Q9NY46 2/20 0.51
ALOX15 P16050 2/20 0.51
CYP3A4 P08684 1/20 0.51
MAPK1 P28482 1/20 0.51
MC4R P32245 1/20 0.51
SCN4A P35499 1/20 0.51
MC3R P41968 1/20 0.51
HTR3A P46098 1/20 0.51
SCN5A Q14524 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30323772 1.00 POLB (0.61) POLBALDH1A1HTTNLRP3HSD17B10
SCHEMBL6769239 0.90 SMN1; SMN2 (0.59) POLBALDH1A1NLRP3SMN1; SMN2LMNA
SCHEMBL307790 0.88 MEN1 (0.62) POLBALDH1A1HTTSMN1; SMN2MEN1
SCHEMBL18297127 0.87 SMN1; SMN2 (0.50) POLBALDH1A1HTTNLRP3SMN1; SMN2
SCHEMBL10893440 0.86 MEN1 (0.50) POLBALDH1A1HTTNLRP3SMN1; SMN2
SCHEMBL12923166 0.86 POLB (0.64) POLBALDH1A1HTTNLRP3HSD17B10
SCHEMBL12812272 0.84 POLB (0.65) POLBALDH1A1HTTNLRP3HSD17B10
SCHEMBL10691650 0.83 POLB (0.61) POLBALDH1A1HTTNLRP3HSD17B10
SCHEMBL11414687 0.83 POLB (0.61) POLBALDH1A1HTTNLRP3HSD17B10
SCHEMBL20194427 0.82 NLRP3 (0.60) POLBALDH1A1HTTNLRP3HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101525302-A Method for coproducing fungicide phosethyl-Al in acetochlor production JINAN KESAIJINONG CHEM CO LTD 2009-09-09 CN claimed
EP-1089628-A1 HERBICIDE Novartis Pharma AG. (CH) 2001-04-11 EP claimed
EP-1089624-A1 HERBICIDAL COMPOSITION Novartis Pharma AG. (CH) 2001-04-11 EP claimed
WO-2000000031-A1 HERBICIDE NOVARTIS PHARMA AG. (CH) 2000-01-06 WO claimed
WO-2000000029-A1 HERBICIDAL COMPOSITION NOVARTIS PHARMA AG. (CH) 2000-01-06 WO claimed
US-4248678-A Alkylating of nitrogen acids using electrogenerated bases as catalysts MONSANTO COMPANY (US) 1981-02-03 US claimed
EP-3185685-A1 MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO Dow AgroSciences LLC (US) 2017-07-05 EP disclosed
US-9469617-B2 Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto DOW AGROSCIENCES LLC (US) 2016-10-18 US disclosed
US-9469617-B2 Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto DOW AGROSCIENCES LLC (US) 2016-10-18 US disclosed
US-9469617-B2 Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto DOW AGROSCIENCES LLC (US) 2016-10-18 US disclosed
US-20160060233-A1 MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO DOW AGROSCIENCES LLC (US) 2016-03-03 US disclosed
WO-2016033025-A1 MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO DOW AGROSCIENCES LLC (US) 2016-03-03 WO disclosed
WO-2016033025-A1 MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO DOW AGROSCIENCES LLC (US) 2016-03-03 WO disclosed
US-4353921-A Antiarrythmic 1-arylcarbamoylalkyl-2-imidazoline derivatives, composition and method of use BERLEX LABORATORIES, INC. (US) 1982-10-12 US disclosed
US-4321081-A Ortho-(trifluoromethylsulfonamido)benzamides as herbicides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1982-03-23 US disclosed
EP-0038636-A2 Sulfonamide derivatives, compositions containing them and their production and use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1981-10-28 EP disclosed
US-4258196-A REACTING THE ANION OF A PRIMARY OR SECONDARY 2-HALOACETAMIDE WITH AN ALKYLATING AGENT MONSANTO COMPANY (US) 1981-03-24 US disclosed
US-4248678-A Alkylating of nitrogen acids using electrogenerated bases as catalysts MONSANTO COMPANY (US) 1981-02-03 US disclosed
US-4237068-A Primary aminoacylanilides ASTRA PHARMACEUTICAL PRODUCTS, INC. (US) 1980-12-02 US disclosed
US-4218477-A LONG LASTING ORAL AGENTS ASTRA PHARMACEUTICAL PRODUCTS, INC. (US) 1980-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160060233-A1 MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO ACHE, DDT, MLYCD POLB 3692/4885ALDH1A1 238/4885HTT 4155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.